Scotia Capital Inc. cut its position in Canopy Growth Co. (NASDAQ:CGC – Get Rating) by 15.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 81,571 shares of the company’s stock after selling 15,409 shares during the quarter. Scotia Capital Inc.’s holdings in Canopy Growth were worth $189,000 at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. Contrarius Investment Management Ltd bought a new position in shares of Canopy Growth in the third quarter worth $53,885,000. ETF Managers Group LLC grew its position in Canopy Growth by 39.6% during the third quarter. ETF Managers Group LLC now owns 10,963,644 shares of the company’s stock worth $29,931,000 after buying an additional 3,107,595 shares in the last quarter. Vanguard Group Inc. increased its stake in Canopy Growth by 26.3% in the 3rd quarter. Vanguard Group Inc. now owns 10,233,037 shares of the company’s stock worth $27,936,000 after acquiring an additional 2,133,358 shares during the last quarter. Two Sigma Advisers LP raised its holdings in shares of Canopy Growth by 148.4% in the 3rd quarter. Two Sigma Advisers LP now owns 2,874,400 shares of the company’s stock valued at $7,847,000 after acquiring an additional 1,717,300 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. boosted its position in shares of Canopy Growth by 59.9% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,616,192 shares of the company’s stock valued at $6,063,000 after acquiring an additional 980,324 shares during the last quarter. 15.82% of the stock is owned by institutional investors.
Canopy Growth Stock Up 3.8 %
CGC opened at $1.09 on Monday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.41 and a current ratio of 1.73. Canopy Growth Co. has a 1 year low of $1.02 and a 1 year high of $5.95. The stock’s 50 day simple moving average is $1.51 and its 200 day simple moving average is $2.37.
Wall Street Analysts Forecast Growth
Canopy Growth Company Profile
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits.
- Get a free copy of the StockNews.com research report on Canopy Growth (CGC)
- What’s Behind The Recent Meteoric Rise Of Tingo Group
- Is PulteGroup Overbought After Double-Digit Gains?
- Netflix Stock Just Had Its Largest Intraday Gain Since 2022
- Analyst Flags Concerns About P&G Growth Despite Earnings Beat
- Is This Why Mike Burry Took a Stake in The RealReal Stock?
Want to see what other hedge funds are holding CGC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Canopy Growth Co. (NASDAQ:CGC – Get Rating).
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.